Globeflex Capital L P Raises Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Globeflex Capital L P grew its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 206,595 shares of the company’s stock after purchasing an additional 1,700 shares during the period. Globeflex Capital L P owned about 0.51% of Phibro Animal Health worth $4,338,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of PAHC. Quantbot Technologies LP purchased a new stake in Phibro Animal Health during the third quarter worth about $70,000. New York State Teachers Retirement System increased its stake in Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after purchasing an additional 775 shares during the period. Amundi increased its stake in Phibro Animal Health by 185.5% during the fourth quarter. Amundi now owns 9,855 shares of the company’s stock worth $212,000 after purchasing an additional 6,403 shares during the period. Zacks Investment Management purchased a new stake in Phibro Animal Health during the third quarter worth about $274,000. Finally, SG Americas Securities LLC increased its stake in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after purchasing an additional 906 shares during the period. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $21.25 on Friday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock has a fifty day moving average price of $22.57 and a 200 day moving average price of $22.56. Phibro Animal Health Co. has a 1-year low of $12.05 and a 1-year high of $26.55. The company has a market cap of $860.69 million, a PE ratio of 44.27, a P/E/G ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Sell-side analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 100.00%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on PAHC shares. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Morgan Stanley increased their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Finally, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Saturday. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $21.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.